Vistagen Therapeuticsincis A Biopharmaceutical Company Based In South San Franciscocaliforniafounded In 1998Vistagen Shifted Its Focus In 2017 To Develop Innovative Treatments For Central Nervous Systemcnsdisordersparticularly Anxiety And Depressionthe Company Is Dedicated To Transforming Mental Health Care Through Pioneering Neurosciencespecifically With Its Pherine Nasal Sprays That Target The Brain Via The Nose To Brain Neurocircuitry Pathway Vistagen S Product Pipeline Includes Lead Drug Candidates That Are Currently In Clinical Trialsthe Company Aims To Address Unmet Medical Needs In Mental Healthfocusing On Individuals Affected By Anxietydepressionand Other Cns Disordersvistagen Is Committed To Advancing Its Research And Development Effortsinvesting Significantly In Its Pipeline To Improve Treatment Options For These Prevalent Conditionsas A Publicly Traded Companyvistagen Offers Broader Investment Opportunities And Maintains Transparency In Its Operations
No conferences found for this company.
| Company Name | Vistagen Therapeutics Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
